SHEL.UK

2,602.5

-1.29%↓

BP

418.05

-0.61%↓

REN

39.78

+0.66%↑

PSON

1,036.5

+0.88%↑

SDR

376

+0.7%↑

SHEL.UK

2,602.5

-1.29%↓

BP

418.05

-0.61%↓

REN

39.78

+0.66%↑

PSON

1,036.5

+0.88%↑

SDR

376

+0.7%↑

SHEL.UK

2,602.5

-1.29%↓

BP

418.05

-0.61%↓

REN

39.78

+0.66%↑

PSON

1,036.5

+0.88%↑

SDR

376

+0.7%↑

SHEL.UK

2,602.5

-1.29%↓

BP

418.05

-0.61%↓

REN

39.78

+0.66%↑

PSON

1,036.5

+0.88%↑

SDR

376

+0.7%↑

SHEL.UK

2,602.5

-1.29%↓

BP

418.05

-0.61%↓

REN

39.78

+0.66%↑

PSON

1,036.5

+0.88%↑

SDR

376

+0.7%↑

Search

Smith & Nephew PLC

Затворен

1,369 -0.47

Преглед

Промяна на цената на акция

24 ч

Текуща

Минимум

1363.5

Максимум

1375.5

Ключови измерители

By Trading Economics

Приходи

296M

Продажби

3B

P/E

Средно за сектора

34.451

35.426

EPS

0.429

Дивидентна доходност

2.69

Марж на печалбата

9.895

Служители

17,000

EBITDA

723M

Препоръки

By TipRanks

Препоръки

Купи

12-месечна прогноза

+2.91% upside

Дивиденти

By Dow Jones

Дивидентна доходност

Средно за сектора

2.69%

4.46%

Следваща дата на дивидент

7.11.2025 г.

Следваща дата на екс-дивидент

2.10.2025 г.

Пазарни показатели

By TradingEconomics

Пазарна капитализация

3.3B

12B

Предишно отваряне

1369.47

Предишно затваряне

1369

Smith & Nephew PLC Графика

Миналото представяне не гарантира бъдещи резултати.

Свързани новини

16.09.2025 г., 17:03 ч. UTC

Значими двигатели на пазара

BrainsWay Shares Rise on FDA Clearance of Major Depressive Disorder Treatment

16.09.2025 г., 16:49 ч. UTC

Значими двигатели на пазара
Придобивния, сливания и поглъщания

GD Culture Shares Drop After Deal for Pallas Capital

16.09.2025 г., 16:11 ч. UTC

Значими двигатели на пазара

Corbus Shares Rise on FDA Fast-Track Designation for Cancer Drug

16.09.2025 г., 23:40 ч. UTC

Пазарно говорене

Nikkei May Decline as Yen Strengthens -- Market Talk

16.09.2025 г., 23:34 ч. UTC

Пазарно говорене

Gold Edges Higher Ahead of FOMC Decision -- Market Talk

16.09.2025 г., 23:20 ч. UTC

Пазарно говорене

Restaurant Brands NZ Can Outperform When Cycle Turns -- Market Talk

16.09.2025 г., 21:10 ч. UTC

Придобивния, сливания и поглъщания

U.S. Investors, Trump Close In on TikTok Deal With China -- WSJ

16.09.2025 г., 20:51 ч. UTC

Пазарно говорене

U.S. Home Sales, New Home Listings Fall in August -- Market Talk

16.09.2025 г., 20:50 ч. UTC

Пазарно говорене

Energy & Utilities Roundup: Market Talk

16.09.2025 г., 20:50 ч. UTC

Пазарно говорене
Придобивния, сливания и поглъщания

Basic Materials Roundup: Market Talk

16.09.2025 г., 20:25 ч. UTC

Печалби

The AI Trade Has Stocks Near Highs Again. Some Tech Names Remain on the Sidelines -- Barrons.com

16.09.2025 г., 20:24 ч. UTC

Печалби

These Stocks Moved the Most Today: Oracle, Tesla, Alphabet, Dave & Buster's, Chipotle, and More -- Barrons.com

16.09.2025 г., 19:19 ч. UTC

Пазарно говорене

U.S. Natural Gas Futures Extend Winning Streak -- Market Talk

16.09.2025 г., 18:52 ч. UTC

Пазарно говорене

Oil Futures Advance on Russia Concerns, Weak Dollar -- Market Talk

16.09.2025 г., 18:44 ч. UTC

Пазарно говорене

Global Equities Roundup: Market Talk

16.09.2025 г., 18:44 ч. UTC

Пазарно говорене

EssilorLuxottica Well-Positioned in Growing Smart-Glasses Market -- Market Talk

16.09.2025 г., 18:40 ч. UTC

Придобивния, сливания и поглъщания

Details Emerge on U.S.-China TikTok Deal -- WSJ

16.09.2025 г., 18:38 ч. UTC

Пазарно говорене

Meta Seen With Long-Term Opportunity to Lead in Smart Glasses -- Market Talk

16.09.2025 г., 18:19 ч. UTC

Пазарно говорене

Gold Settles at New High Ahead of Fed Decision -- Market Talk

16.09.2025 г., 18:01 ч. UTC

Пазарно говорене

U.S. Dollar Weakness Supports Oil's Gains -- Market Talk

16.09.2025 г., 17:34 ч. UTC

Пазарно говорене

Any Question the Bank of Canada Will Cut Now Look to Have Vanished -- Market Talk

16.09.2025 г., 16:53 ч. UTC

Печалби

Software Companies Are Fighting Back With AI. The Stocks Are Still Hurting. -- Barrons.com

16.09.2025 г., 16:20 ч. UTC

Пазарно говорене
Придобивния, сливания и поглъщания

Basic Materials Roundup: Market Talk

16.09.2025 г., 16:15 ч. UTC

Пазарно говорене
Придобивния, сливания и поглъщания

Global Commodities Roundup: Market Talk

16.09.2025 г., 16:09 ч. UTC

Пазарно говорене
Придобивния, сливания и поглъщания

Global Energy Roundup: Market Talk

16.09.2025 г., 16:09 ч. UTC

Пазарно говорене
Придобивния, сливания и поглъщания

Canada Industry Minister to Meet Mining CEOs on Merger -- Market Talk

16.09.2025 г., 15:35 ч. UTC

Пазарно говорене

Global Forex and Fixed Income Roundup: Market Talk

16.09.2025 г., 15:35 ч. UTC

Пазарно говорене

Gold Soars Past $3,700 Ahead of Fed Decision -- Market Talk

16.09.2025 г., 15:22 ч. UTC

Пазарно говорене

More Investors Think Dollar is Overvalued in Latest BofA Survey -- Market Talk

16.09.2025 г., 15:21 ч. UTC

Пазарно говорене

Sterling Considered Most Overvalued in Nearly 10 Years -- Market Talk

Сравнение с други в отрасъла

Ценова промяна

Smith & Nephew PLC Прогноза

Ценова цел

By TipRanks

2.91% нагоре

12-месечна прогноза

Среден 1,425.25 GBX  2.91%

Висок 1,700 GBX

Нисък 1,250 GBX

Според 12 анализатори от Wall Street, предложили 12-месечна ценова цел за Smith & Nephew PLC през последните три месеца.

Консенсусна оценка

By TipRanks

Купи

12 ratings

7

Купи

5

Задържане

0

Продай

Финанси

Продажбени и админисративни разходи

Оперативни разходи

Печалба преди облагане с данъци

Продажби

Разходи за продажби

Брутна печалба от продажби

Разходи за лихви по дълг

EBITDA

Оперативна печалба

$

Относно Smith & Nephew PLC

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom and internationally. It operates through three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. The company offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures; and other reconstruction products. It also provides sports medicine joint repair products comprise instruments, technologies, and implants to perform minimally invasive surgery, as well as treating soft tissue injuries and degenerative conditions of the shoulder, knee, hip, and small joints. In addition, the company offers arthroscopic enabling technologies comprising fluid management equipment for surgical access, high-definition cameras, digital image capture, scopes, light sources, and monitors to assist with visualization inside the joints, radio frequency, electromechanical and mechanical tissue resection devices, and hand instruments for removing damaged tissue; and ear, nose, and throat solutions. Further, it provides advanced wound care products for the treatment and prevention of acute and chronic wounds, which comprise leg wounds, diabetic and pressure ulcers, burns, and post-operative wounds; advanced wound bioactives, such as biologics and other bioactive technologies for debridement and dermal repair/regeneration, and regenerative medicine products, including skin, bone graft, and articular cartilage substitutes; and advanced wound devices, such as traditional and single-use negative pressure wound therapy, and hydrosurgery systems. The company serves the healthcare providers. Smith & Nephew plc was founded in 1856 and is headquartered in Watford, the United Kingdom.
help-icon Live chat